Known for its scientific and operational excellence, Regeneron is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.
The Metabolic and Muscle Disease Group at Regeneron is committed to discovering novel targets and innovative medicines to treat diabetes, obesity, dyslipidemia and muscle diseases. We are seeking someone with strong command of molecular biology, biochemistry, in vitro assay development, and in vivo pharmacology to help advance the metabolic and muscle antibody project portfolio and provide validation for new projects. The candidate would be responsible for providing scientific direction, technical expertise and leadership, coordinating activities with project teams and other groups across the organization.
Identify novel approaches and targets for drug development. Design and perform in vitro and in vivo studies for new target validation and to support antibody-based drug development.
Broad experience in molecular biology, biochemistry, in vitro assay development and in vivo pharmacology is essential.
Responsible for providing lab direction, technical expertise and coordinating activities with other groups at Regeneron. Participates in staff development, resource allocation and performance management.